Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul P Cook

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
North Carolina Medical Journal|September 14, 2016
What Is New in Infectious Diseases?Paul P Cook
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2006
Rifampin and pyrazinamide for treatment of latent tuberculosis infectionPaul P Cook
International Journal of Antimicrobial Agents|January 3, 2015
Long-term effects of an antimicrobial stewardship programme at a tertiary-care teaching hospitalPaul P Cook, Michael Gooch
North Carolina Medical Journal|September 14, 2016
Antibiotic Misuse in Hospital, Outpatient, and Long-Term Care SettingsMuhammad Salman Ashraf, Paul P Cook
Antimicrobial Agents and Chemotherapy|October 5, 2011
Reduction in fluoroquinolone use following introduction of ertapenem into a hospital formulary is associated with improvement in susceptibility of Pseudomonas aeruginosa to group 2 carbapenems: a 10-year studyPaul P Cook, Michael Gooch, Shemra Rizzo
RNA Biology|December 14, 2021
Cellular miR-150-5p may have a crucial role to play in the biology of SARS-CoV-2 infection by regulating <i>nsp10</i> geneShaw M Akula, Paul Bolin, Paul P Cook
Journal of Hospital Medicine|October 10, 2013
Risk of redocumenting penicillin allergy in a cohort of patients with negative penicillin skin testsRamzy H Rimawi, Kaushal B Shah, Paul P Cook
Critical Care Medicine|March 18, 2014
The authors replyRamzy H Rimawi, Paul P Cook, Mark A Mazer
Infection Control and Hospital Epidemiology|March 16, 2012
Decreased resistance of Pseudomonas aeruginosa with restriction of ciprofloxacin in a large teaching hospital's intensive care and intermediate care unitsG Jonathan Lewis, Xiangming Fang, Michael Gooch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2006
Safety and completion rate of short-course therapy for treatment of latent tuberculosis infectionPaul P Cook, Ricardo A Maldonado, Connie T Yarnell, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
North Carolina Medical Journal|September 14, 2016
What Is New in Infectious Diseases?Paul P Cook
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2006
Rifampin and pyrazinamide for treatment of latent tuberculosis infectionPaul P Cook
International Journal of Antimicrobial Agents|January 3, 2015
Long-term effects of an antimicrobial stewardship programme at a tertiary-care teaching hospitalPaul P Cook, Michael Gooch
North Carolina Medical Journal|September 14, 2016
Antibiotic Misuse in Hospital, Outpatient, and Long-Term Care SettingsMuhammad Salman Ashraf, Paul P Cook
Antimicrobial Agents and Chemotherapy|October 5, 2011
Reduction in fluoroquinolone use following introduction of ertapenem into a hospital formulary is associated with improvement in susceptibility of Pseudomonas aeruginosa to group 2 carbapenems: a 10-year studyPaul P Cook, Michael Gooch, Shemra Rizzo
RNA Biology|December 14, 2021
Cellular miR-150-5p may have a crucial role to play in the biology of SARS-CoV-2 infection by regulating <i>nsp10</i> geneShaw M Akula, Paul Bolin, Paul P Cook
Journal of Hospital Medicine|October 10, 2013
Risk of redocumenting penicillin allergy in a cohort of patients with negative penicillin skin testsRamzy H Rimawi, Kaushal B Shah, Paul P Cook
Critical Care Medicine|March 18, 2014
The authors replyRamzy H Rimawi, Paul P Cook, Mark A Mazer
Infection Control and Hospital Epidemiology|March 16, 2012
Decreased resistance of Pseudomonas aeruginosa with restriction of ciprofloxacin in a large teaching hospital's intensive care and intermediate care unitsG Jonathan Lewis, Xiangming Fang, Michael Gooch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2006
Safety and completion rate of short-course therapy for treatment of latent tuberculosis infectionPaul P Cook, Ricardo A Maldonado, Connie T Yarnell, et al.
Pageof 4